…ute pancreatitis (2.4% vs 10.8%; HR 0.247, 95% CI 0.149–0.409), pancreatic cancer (0.7% vs 3.0%; HR 0.255, 95% CI 0.128–0.511), composite gastroi…
CP
This disease is selected. Its supporting articles are shown below.
Articles mentioning CP
25 articles · page 2 of 3… placebo; OR 0.76, 95% CI 0.27 to 2.12; p=0.60). Development of diabetes mellitus was more frequent in the simvastatin group (4 vs 0 patients; OR…
…Background Respiratory disease is a leading cause of hospitalisations in children with cerebra…
… structural damage, lifelong metabolic and functional sequelae, pancreatic cancer risk and poor quality of life. Against this backdrop, the repur…
…placebo in patients with recurrent acute pancreatitis (RAP) and chronic pancreatitis (CP) in reducing the recurrence of pancreatitis. Statins have p…
… been elated to see the recent flurry of publications by Gut on chronic pancreatitis (CP) associated with mutations of the pancreatic digestive enzy…
…ing Programme’ (VISP).Interventions VISP includes screening for lower extremity artery disease (LEAD), carotid plaque (CP), abdominal aortic aneurysm (AAA), h…
…e To determine the predictive accuracy of an early high risk of cerebral palsy (CP) classification for CP diagnosed by 2 years’ corrected age …
…facilitating opioid tapering in chronic pain (CP) patients with opioid use disorder.1 The study included 59 patients, 42 of which completed 12-mont…
…Children and young people (CYP) with cerebral palsy (CP) are increasingly being commenced on long-term respiratory …
…ILE) is an intensive rehabilitation programme for children with cerebral palsy (CP) delivered in a day camp setting recognised to promote the …
…Background The lifelong care responsibilities associated with cerebral palsy (CP) may place significant physical and psychological burdens o…